331 related articles for article (PubMed ID: 23960212)
1. CB1 and CB2 cannabinoid receptor antagonists prevent minocycline-induced neuroprotection following traumatic brain injury in mice.
Lopez-Rodriguez AB; Siopi E; Finn DP; Marchand-Leroux C; Garcia-Segura LM; Jafarian-Tehrani M; Viveros MP
Cereb Cortex; 2015 Jan; 25(1):35-45. PubMed ID: 23960212
[TBL] [Abstract][Full Text] [Related]
2. CB2 cannabinoid receptor is involved in the anti-inflammatory effects of leptin in a model of traumatic brain injury.
Lopez-Rodriguez AB; Mela V; Acaz-Fonseca E; Garcia-Segura LM; Viveros MP
Exp Neurol; 2016 May; 279():274-282. PubMed ID: 27006282
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid CB
Weresa J; Pędzińska-Betiuk A; Kossakowski R; Malinowska B
Pharmacol Rep; 2019 Feb; 71(1):82-89. PubMed ID: 30500553
[TBL] [Abstract][Full Text] [Related]
4. Blockade of acute microglial activation by minocycline promotes neuroprotection and reduces locomotor hyperactivity after closed head injury in mice: a twelve-week follow-up study.
Homsi S; Piaggio T; Croci N; Noble F; Plotkine M; Marchand-Leroux C; Jafarian-Tehrani M
J Neurotrauma; 2010 May; 27(5):911-21. PubMed ID: 20166806
[TBL] [Abstract][Full Text] [Related]
5. Minocycline Attenuates Neonatal Germinal-Matrix-Hemorrhage-Induced Neuroinflammation and Brain Edema by Activating Cannabinoid Receptor 2.
Tang J; Chen Q; Guo J; Yang L; Tao Y; Li L; Miao H; Feng H; Chen Z; Zhu G
Mol Neurobiol; 2016 Apr; 53(3):1935-1948. PubMed ID: 25833102
[TBL] [Abstract][Full Text] [Related]
6. Transient neuroprotection by minocycline following traumatic brain injury is associated with attenuated microglial activation but no changes in cell apoptosis or neutrophil infiltration.
Bye N; Habgood MD; Callaway JK; Malakooti N; Potter A; Kossmann T; Morganti-Kossmann MC
Exp Neurol; 2007 Mar; 204(1):220-33. PubMed ID: 17188268
[TBL] [Abstract][Full Text] [Related]
7. Changes in cannabinoid receptors, aquaporin 4 and vimentin expression after traumatic brain injury in adolescent male mice. Association with edema and neurological deficit.
Lopez-Rodriguez AB; Acaz-Fonseca E; Viveros MP; Garcia-Segura LM
PLoS One; 2015; 10(6):e0128782. PubMed ID: 26039099
[TBL] [Abstract][Full Text] [Related]
8. Cannabidiol inhibits sucrose self-administration by CB1 and CB2 receptor mechanisms in rodents.
Bi GH; Galaj E; He Y; Xi ZX
Addict Biol; 2020 Jul; 25(4):e12783. PubMed ID: 31215752
[TBL] [Abstract][Full Text] [Related]
9. Granulocyte Colony-Stimulating Factor Enhances Brain Repair Following Traumatic Brain Injury Without Requiring Activation of Cannabinoid Receptors.
Song S; Kong X; Borlongan C; Sava V; Sanchez-Ramos J
Cannabis Cannabinoid Res; 2021; 6(1):48-57. PubMed ID: 33614952
[No Abstract] [Full Text] [Related]
10. Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile.
Gómez-Cañas M; Morales P; García-Toscano L; Navarrete C; Muñoz E; Jagerovic N; Fernández-Ruiz J; García-Arencibia M; Pazos MR
Pharmacol Res; 2016 Aug; 110():205-215. PubMed ID: 27013280
[TBL] [Abstract][Full Text] [Related]
11. Remote Ischemia Preconditioning Attenuates Blood-Spinal Cord Barrier Breakdown in Rats Undergoing Spinal Cord Ischemia Reperfusion Injury: Associated with Activation and Upregulation of CB1 and CB2 Receptors.
Jing N; Fang B; Wang ZL; Ma H
Cell Physiol Biochem; 2017; 43(6):2516-2524. PubMed ID: 29130941
[TBL] [Abstract][Full Text] [Related]
12. Involvement of ERK1/2, cPLA2 and NF-κB in microglia suppression by cannabinoid receptor agonists and antagonists.
Ribeiro R; Wen J; Li S; Zhang Y
Prostaglandins Other Lipid Mediat; 2013 Jan; 100-101():1-14. PubMed ID: 23219970
[TBL] [Abstract][Full Text] [Related]
13. The fatty acid amide hydrolase inhibitor PF-3845 promotes neuronal survival, attenuates inflammation and improves functional recovery in mice with traumatic brain injury.
Tchantchou F; Tucker LB; Fu AH; Bluett RJ; McCabe JT; Patel S; Zhang Y
Neuropharmacology; 2014 Oct; 85():427-39. PubMed ID: 24937045
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid receptor antagonists and fatty acids alter endocannabinoid system gene expression and COX activity.
Kim J; Watkins BA
J Nutr Biochem; 2014 Aug; 25(8):815-23. PubMed ID: 24854955
[TBL] [Abstract][Full Text] [Related]
15. Opposite effects of cannabinoid CB
Li L; Dong X; Tu C; Li X; Peng Z; Zhou Y; Zhang D; Jiang J; Burke A; Zhao Z; Jin L; Jiang Y
Br J Pharmacol; 2019 Apr; 176(7):890-905. PubMed ID: 30707759
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoid CB2 receptor stimulation attenuates brain edema and neurological deficits in a germinal matrix hemorrhage rat model.
Tao Y; Tang J; Chen Q; Guo J; Li L; Yang L; Feng H; Zhu G; Chen Z
Brain Res; 2015 Mar; 1602():127-35. PubMed ID: 25625355
[TBL] [Abstract][Full Text] [Related]
17. Differential modulation of endogenous cannabinoid CB1 and CB2 receptors in spontaneous and splice variants of ghrelin-induced food intake in conscious rats.
Ting CH; Chi CW; Li CP; Chen CY
Nutrition; 2015 Jan; 31(1):230-5. PubMed ID: 25466669
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of morphine antinociceptive tolerance by cannabinoid CB1 and CB2 receptor antagonists.
Altun A; Yildirim K; Ozdemir E; Bagcivan I; Gursoy S; Durmus N
J Physiol Sci; 2015 Sep; 65(5):407-15. PubMed ID: 25894754
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid system involves in the analgesic effect of protocatechuic acid.
Dikmen DY; Okcay Y; Arslan R; Bektas N
Daru; 2019 Dec; 27(2):605-612. PubMed ID: 31325037
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid receptor subtypes 1 and 2 mediate long-lasting neuroprotection and improve motor behavior deficits after transient focal cerebral ischemia.
Schmidt W; Schäfer F; Striggow V; Fröhlich K; Striggow F
Neuroscience; 2012 Dec; 227():313-26. PubMed ID: 23069763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
